Thermo Fisher Scientific (TMO) Acquisitions (2009 - 2026)

Thermo Fisher Scientific has disclosed Acquisitions across 17 years of filings, most recently posting $8.9 billion for Q1 2026.

• Quarterly Acquisitions changed N/A year-over-year to $8.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.9 billion (up 183.27% YoY) and the FY2025 annual result came in at $4.0 billion, up 28.9% from the prior year.
• Acquisitions climbed to $8.9 billion in Q1 2026, from $3.1 billion in the prior quarter.
• Over five years, Acquisitions peaked at $8.9 billion in Q1 2026 and troughed at -$1.0 million in Q4 2022.
• A 4-year average of $2.2 billion and a median of $909.0 million in 2023 frame the typical range for Acquisitions.
• Annual changes were most pronounced in 2022 — Acquisitions tumbled 101.06% — and 2023, when it jumped 91000.0%.
• Tracing TMO's Acquisitions over 4 years: stood at -$1.0 million in 2022, then soared by 91000.0% to $909.0 million in 2023, then jumped by 244.55% to $3.1 billion in 2024, then soared by 183.27% to $8.9 billion in 2026.
• Business Quant data shows TMO's Acquisitions at $8.9 billion in Q1 2026, $3.1 billion in Q3 2024, and $909.0 million in Q3 2023.